GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akorn, Inc. (AKRX) [hlAlert]

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from
outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.
.
( Total: 10 Current Stock Recommendations )
Akorn, Inc.   (10)
Hold 20% Buy 80%
Related companies
Opko Health Inc   (3)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Talecris ...   (4)
Buy 100%
King ...   (13)
Sell Hold 62% Buy 31%
Mylan Laboratories, ...   (19)
Hold 32% Buy 68%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 20% Buy 60%
Filter by Gains:   
  
Rating:
Buy AKRX
up 309.03 %
Akorn, Inc. (AKRX) rated Buy with price target $28 by Needham
Tuesday,  Mar 4, 2014  8:25 AM ET

Rating:
Buy AKRX
up 138.09 %
Akorn, Inc. (AKRX) rated Buy by Guggenheim
Thursday,  Sep 26, 2013  8:25 AM ET

Rating:
Buy AKRX
up 309.03 %
Akorn, Inc. (AKRX) rated Buy with price target $22 by Needham
Wednesday,  Aug 28, 2013  8:25 AM ET

Rating:
Buy AKRX
up 309.03 %
Akorn, Inc. (AKRX) rated Buy with price target $18 by Needham
Wednesday,  Aug 7, 2013  8:25 AM ET

Rating:
Hold AKRX

Rating:
Buy AKRX
up 239.29 %
Akorn, Inc. (AKRX) rated Outperform by Leerink Swann
Thursday,  Sep 27, 2012  8:25 AM ET

Rating:
Buy AKRX
up 254.18 %
Akorn, Inc. (AKRX) rated Buy by BofA/Merrill
Wednesday,  Sep 26, 2012  8:25 AM ET

Rating:
Hold AKRX
up 6.17 %

Rating:
Buy AKRX
up 226.08 %
Akorn, Inc. (AKRX) rated Buy with price target $16 by Auriga
Wednesday,  May 23, 2012  1:25 PM ET

Rating:
Buy AKRX
up 309.03 %
Akorn, Inc. (AKRX) rated Buy with price target $14 by Needham
Wednesday,  Mar 7, 2012  8:25 AM ET

Rating:
Buy AKRX
up 6.17 %

Rating:
Buy AKRX
up 309.03 %
Akorn, Inc. (AKRX) rated Buy with price target $13 by Needham
Wednesday,  Jan 18, 2012  8:25 AM ET

Rating:
Buy AKRX
up 392.56 %

Rating:
Buy AKRX
up 392.56 %

Rating:
Buy AKRX
up 1,291.22 %

Your Recent Stocks
SymbolLastChange
AKRX 43.64 down  -1.66 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy